Candesartan and renal protection: More than blocking angiotensin type 1 receptor?

Daniela Macconi, Giuseppe Remuzzi

Research output: Contribution to journal › Article

3 Citations (Scopus)

Abstract

Chen et al. show that candesartan (Cand) displays an antioxidant action independent of angiotensin type 1 receptor (AT1R) blockade that translates into a superior renoprotection of chronic renal inflammation. The peculiarity of Cand in combining AT1R-blocking activity and an antioxidant action could have important theoretical implications for therapy.

Original languageEnglish
Pages (from-to)1112-1114
Number of pages3
JournalKidney International
Volume74
Issue number9
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Angiotensin Type 1 Receptor
Antioxidants
Kidney
Inflammation
candesartan
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Candesartan and renal protection : More than blocking angiotensin type 1 receptor? / Macconi, Daniela; Remuzzi, Giuseppe.

In: Kidney International, Vol. 74, No. 9, 11.2008, p. 1112-1114.

Research output: Contribution to journal › Article

Macconi, D & Remuzzi, G 2008, 'Candesartan and renal protection: More than blocking angiotensin type 1 receptor?', Kidney International, vol. 74, no. 9, pp. 1112-1114. https://doi.org/10.1038/ki.2008.420
Macconi D, Remuzzi G. Candesartan and renal protection: More than blocking angiotensin type 1 receptor? Kidney International. 2008 Nov;74(9):1112-1114. https://doi.org/10.1038/ki.2008.420
Macconi, Daniela ; Remuzzi, Giuseppe. / Candesartan and renal protection : More than blocking angiotensin type 1 receptor?. In: Kidney International. 2008 ; Vol. 74, No. 9. pp. 1112-1114.
@article{dcd94d10df7b45d28823cd724edc0ab5,
title = "Candesartan and renal protection: More than blocking angiotensin type 1 receptor?",
abstract = "Chen et al. show that candesartan (Cand) displays an antioxidant action independent of angiotensin type 1 receptor (AT1R) blockade that translates into a superior renoprotection of chronic renal inflammation. The peculiarity of Cand in combining AT1R-blocking activity and an antioxidant action could have important theoretical implications for therapy.",
author = "Daniela Macconi and Giuseppe Remuzzi",
year = "2008",
month = "11",
doi = "10.1038/ki.2008.420",
language = "English",
volume = "74",
pages = "1112--1114",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Candesartan and renal protection

T2 - More than blocking angiotensin type 1 receptor?

AU - Macconi, Daniela

AU - Remuzzi, Giuseppe

PY - 2008/11

Y1 - 2008/11

N2 - Chen et al. show that candesartan (Cand) displays an antioxidant action independent of angiotensin type 1 receptor (AT1R) blockade that translates into a superior renoprotection of chronic renal inflammation. The peculiarity of Cand in combining AT1R-blocking activity and an antioxidant action could have important theoretical implications for therapy.

AB - Chen et al. show that candesartan (Cand) displays an antioxidant action independent of angiotensin type 1 receptor (AT1R) blockade that translates into a superior renoprotection of chronic renal inflammation. The peculiarity of Cand in combining AT1R-blocking activity and an antioxidant action could have important theoretical implications for therapy.

UR - http://www.scopus.com/inward/record.url?scp=53949124356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53949124356&partnerID=8YFLogxK

U2 - 10.1038/ki.2008.420

DO - 10.1038/ki.2008.420

M3 - Article

C2 - 18854846

AN - SCOPUS:53949124356

VL - 74

SP - 1112

EP - 1114

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 9

ER -

Access to Document